-
Ipsen Appoints Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer
americanpharmaceuticalreview
April 17, 2017
Ipsen has announced the appointment of Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer, effective immediately.
-
Ipsen Names Executive Vice President and President, Primary Care
americanpharmaceuticalreview
March 03, 2017
Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President, Primary Care, effective 13 March 2017. Mr. Hennion will report directly to David Meek, CEO of Ipsen,
-
Ipsen to acquire five consumer healthcare products from Sanofi
pharmaceutical-technology
February 15, 2017
French pharmaceutical company Ipsen has signed an agreement to acquire five consumer healthcare products in certain European territories from Sanofi for €83m.
-
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
americanpharmaceuticalreview
February 15, 2017
Ipsen has entered into a definitive agreement to acquire from Sanofi five consumer healthcare products in certain European territories.
-
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
americanpharmaceuticalreview
February 06, 2017
Ipsen has signed an agreement to take an equity stake in Akkadeas Pharma with an option to take control of the company in the future. Akkadeas Pharma is a privately-held consumer health care company in Italy with a diversified gastrointestinal-focused por